Candriam SCA’s Akcea Therapeutics Inc AKCA Stock Holding History

Candriam SCA’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-244,395	Closed	-$4.43M	–	870
2020 Q3	$4.43M	Buy	+244,395	New	+$3.47M	0.04%	372
2018 Q1	–	Sell	-114,571	Closed	-$1.99M	–	799
2017 Q4	$1.99M	Sell	114,571 -77,487	-40%	-$1.52M	0.03%	456
2017 Q3	$5.31M	Buy	+192,058	New	+$3.56M	0.09%	254

Candriam SCA's AKCA Position: Q4 2020 in Review

Candriam SCA sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 244,395 shares — an estimated $4.43M sold.

Candriam SCA first reported a position in AKCA in Q3 2017 and held it in 3 quarters. The position peaked at $5.31M in Q3 2017. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Candriam SCA reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Candriam SCA sold 244,395 Akcea Therapeutics Inc shares in Q4 2020, an estimated $4.43M.
Candriam SCA first reported a position in Akcea Therapeutics Inc in Q3 2017 and held it in 3 quarters.
Candriam SCA's Akcea Therapeutics Inc position peaked at $5.31M in Q3 2017.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Candriam SCA's 13F filing for Q4 2020, filed 22 Jan 2021.